BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34040057)

  • 1. Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data.
    Katiyar A; Kaur G; Rani L; Jena L; Singh H; Kumar L; Sharma A; Kaur P; Gupta R
    Sci Rep; 2021 May; 11(1):10957. PubMed ID: 34040057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
    Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
    Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an miRNA-mRNA regulatory network in colorectal cancer with bioinformatics methods.
    Su Y; Zhang M; Zhang L; Chen S; Zhang D; Zhang X
    Anticancer Drugs; 2019 Jul; 30(6):588-595. PubMed ID: 30601194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an MiRNA-mRNA Regulatory Network in Colorectal Cancer.
    Cui MF; Wu YY; Chen MY; Zhao Y; Han SY; Wang RJ; Zhang H; Fang XD
    Comb Chem High Throughput Screen; 2021; 24(10):1736-1745. PubMed ID: 33172374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
    Peng Y; Song X; Lan J; Wang X; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
    Gao H; Wang H; Yang W
    Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
    Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
    Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma.
    Cui Z; Song Q; Chen Y; Yang K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):280-289. PubMed ID: 35132271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
    Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
    Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
    Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
    Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
    Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G
    Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
    Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
    Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma.
    Ghosal S; Banerjee S
    Med Oncol; 2022 Feb; 39(5):53. PubMed ID: 35150335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.